After the legalization of the constitutional right of women to abortion in the United States with the case Roe vs. Wade, the door was opened to many consequences that this decision brought with it. One of these consequences is the illegal sale of organs and tissues extracted in abortions. In the present article a bioethical and biolegal analysis will be developed of the case that brought to light that slippery slope of the legalization of abortion, this is the case of the research of the non-profit organization, Center for Medical Progress (CMP) to the multinational abortion, Planned Parenthood, and the consequent investigation and final report presented by the Select Panel of the Committee on Energy and Commerce of the US House of Representatives.

Since the discovery of the double helix by Watson and Crick, biotechnological advances related to the world of genetics, have yielded rapid jumps for humanity. Major milestones such as DNA sequencing, the Human Genome Project, the cloning of the Dolly sheep, and even the development of genetically modified phosphorescent cats to shine in the dark, among others, have been possible with these advances. Genetic engineering is a possibility thanks to this development of science, and so since 2012, the emergence of a new technique that uses the system known as CRISPR/Cas9 has opened the borders globally, to the era of gene editing, in a faster, easier and more accessible way. When talking about new technologies of genetic modification, especially if it is about the modification of the germ line, the bioethical impact must be